VTYX
NASDAQ · Pharmaceuticals
Ventyx Biosciences Inc
$14.00
+0.02 (+0.14%)
Open$13.99
Previous Close$13.98
Day High$14.00
Day Low$13.99
52W High$25.00
52W Low$7.08
Volume—
Avg Volume4.20M
Market Cap1.00B
P/E Ratio—
EPS$-1.50
SectorPharmaceuticals
Analyst Ratings
Hold
15 analysts
Price Target
+351.1% upside
Current
$14.00
$14.00
Target
$63.16
$63.16
$39.88
$63.16 avg
$74.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.43M | 24.73M | 29.85M |
| Net Income | 6.42M | 4.69M | 6.83M |
| Profit Margin | 23.4% | 19.0% | 22.9% |
| EBITDA | 7.71M | 7.29M | 9.18M |
| Free Cash Flow | 5.17M | 5.81M | 4.69M |
| Rev Growth | -7.8% | +2.8% | +7.3% |
| Debt/Equity | 0.43 | 0.48 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,422.11 | +0.72% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.96 | -0.05% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.82 | -1.30% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.25 | +0.07% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.20 | +0.10% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $81.95 | -0.45% | 12.8 | 33.59B |